A decline in Puma levels did not increase Mcl-1–Mule complex (data not shown) or ubiquitination of Mcl-1 as assessed by immunoprecipitation and western analysis in breast cancer cells (Figure 5B, right panel). This evidence concerns the gene BBC3 and breast carcinoma.